moxifloxacin
Next-generation Cempra antibiotic meets endpoints
January 5, 2015Research and Development, Sales and Marketing Antibiotics, FDA, cempra, moxifloxacin, solitaire-oral
Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
